ETPrime

Godavari Drugs Share Price

  • 81.700.57 (0.70%)
  • Volume: 2,110
BSE
  • Closed
  • Last Updated On: 16 Oct, 2025, 03:43 PM IST
STOCK SCORE
ETPrime Only
High: "NaN",Open: "NaN",Low: "NaN",
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Godavari Drugs Share Price
  • 81.700.57 (0.70%)
  • Volume: 2,110
Advertisment

Key Metrics

PE Ratio
(x)		16.23
EPS - TTM
(₹)		5.03
MCap
(₹ Cr.)		61.52
Sectoral MCap Rank
142
PB Ratio
(x)		1.41
Div Yield
(%)		0.00
Face Value
(₹)		10.00
Beta

Beta

1 Month-0.47
3 Months0.18
6 Months0.33
1 Year0.33
3 Years0.88

-0.47
VWAP
(₹)		80.26
52W H/L
(₹)
142.50 / 78.91

Godavari Drugs share price insights

  • Company has spent 4.17% of its operating revenues towards interest expenses and 4.44% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Godavari Drugs Ltd. share price moved up by 0.70% from its previous close of Rs 81.13. Godavari Drugs Ltd. stock last traded price is 81.70

    Share PriceValue
    Today/Current/Last-81.70
    Previous Day-81.13

InsightsGodavari Drugs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Godavari Drugs Share Price Returns

    1 Day0.7%
    1 Week0.12%
    1 Month-5.49%
    3 Months-8.48%
    1 Year-39.1%
    3 Years17.47%
    5 Years125.69%

    ET Stock ScreenersTop Score Companies

    Check whether Godavari Drugs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Godavari Drugs News & Analysis

    View all Godavari Drugs Share News & Announcements

    Godavari Drugs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Godavari Drugs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Godavari Drugs Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 4.17% of its operating revenues towards interest expenses and 4.44% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income23.8225.6129.6526.1032.97
      Total Income Growth (%)-6.97-13.6313.61-20.85-14.91
      Total Expenses21.5223.0627.6223.7729.53
      Total Expenses Growth (%)-6.70-16.5016.21-19.51-14.99
      EBIT2.312.552.032.333.45
      EBIT Growth (%)-9.4325.40-12.90-32.36-14.28
      Profit after Tax (PAT)1.040.890.771.091.63
      PAT Growth (%)16.5216.38-29.51-33.25-38.74
      EBIT Margin (%)9.689.956.858.9410.46
      Net Profit Margin (%)4.373.492.594.174.95
      Basic EPS (₹)1.381.191.021.452.17
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue114.33157.33160.28161.38123.08
      Total Revenue Growth (%)-27.33-1.84-0.6831.1228.17
      Total Expenses108.70150.32155.57154.36117.37
      Total Expenses Growth (%)-27.68-3.380.7931.5125.22
      Profit after Tax (PAT)4.385.553.795.254.13
      PAT Growth (%)-21.0746.57-27.8227.06106.32
      Operating Profit Margin (%)9.137.615.406.127.34
      Net Profit Margin (%)3.863.542.373.253.36
      Basic EPS (₹)5.827.375.036.975.48

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets143.08134.75121.43101.4191.14
      Total Assets Growth (%)6.1810.9719.7411.278.60
      Total Liabilities99.7395.7988.0271.7866.75
      Total Liabilities Growth (%)4.118.8322.627.544.85
      Total Equity43.3538.9733.4229.6324.39
      Total Equity Growth (%)11.2416.6112.7921.4820.38
      Current Ratio (x)1.081.081.181.291.34
      Total Debt to Equity (x)1.421.431.000.691.15
      Contingent Liabilities0.000.500.500.390.30

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 19.51 cr for investing activities which is an YoY increase of 47.58%. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities11.2018.4113.2211.231.33
      Net Cash used in Investing Activities-19.51-13.22-8.64-4.97-1.25
      Net Cash flow from Financing Activities8.07-5.65-3.77-5.620.13
      Net Cash Flow-0.25-0.460.810.640.21
      Closing Cash & Cash Equivalent2.372.623.082.281.64
      Closing Cash & Cash Equivalent Growth (%)-9.52-14.9735.5138.9514.84
      Total Debt/ CFO (x)5.503.022.531.8121.15

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)10.1014.2411.3217.7016.92
      Return on Capital Employed (%)14.7922.6018.0822.6122.18
      Return on Assets (%)3.064.113.115.174.52
      Interest Coverage Ratio (x)2.712.832.694.062.73
      Asset Turnover Ratio (x)0.821.221.431.67134.59
      Price to Earnings (x)15.0612.6315.089.408.35
      Price to Book (x)1.521.801.711.661.41
      EV/EBITDA (x)9.778.838.275.825.95
      EBITDA Margin (%)11.298.886.627.178.34

      No reported Financial Ratios are available.

    Financial InsightsGodavari Drugs

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 4.17% of its operating revenues towards interest expenses and 4.44% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 19.51 cr for investing activities which is an YoY increase of 47.58%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Godavari Drugs Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Godavari Drugs Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Godavari Drugs16.231.4210.1014.793.06-10.759.133.865.821.081.425.50
          Ind Swift Ltd0.30-0.21-70.4510.5338.9310.039.1455.0152.331.42-2.1755.11
          Sunil Healthcare421.431.15-2.115.28-0.87-11.046.28-1.69-1.381.041.025.96
          Transchem Ltd16.120.936.588.896.5518.58268.51198.674.27257.860.000.00
          Biofil Chem22.963.422.964.041.0914.212.311.660.341.340.03-0.24
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Concord Drugs
          • Vista Pharma
          • Kabra Drugs
          • Medi-Caps Ltd
          • Roopa Ind

          Choose from Stocks

            See All Parameters

          Peers InsightsGodavari Drugs

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Godavari Drugs Shareholding Pattern

            • Loading...
              Showing Godavari Drugs Shareholding as on Sep 2025
              CategorySep 2025Jun 2025Mar 2025Dec 2024
              Promoters52.6152.6352.6352.63
              Pledge0.220.250.250.25
              FII0.000.000.000.00
              DII0.000.000.000.00
              Mutual Funds0.000.000.000.00
              Others47.3947.3747.3747.37
            • Showing Shareholding as on Sep 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters39,61,73152.61 %-0.02
              Pledge8,5310.22 %-0.03
              Others35,68,76947.39 %0.02

            Godavari Drugs MF Ownership

            MF Ownership details are not available.

            Top Searches:
            Godavari Drugs News Godavari Drugs Quarterly Results Godavari Drugs Dividend Godavari Drugs Q1 ResultsGodavari Drugs Q2 ResultsGodavari Drugs Q3 ResultsGodavari Drugs Q4 Results

            Godavari Drugs Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Sep 27, 2025Aug 04, 2025AGM(Revised)
              Aug 13, 2025Aug 01, 2025Board MeetingQuarterly Results & A.G.M.
              Aug 13, 2025Aug 04, 2025AGM-
              May 29, 2025May 26, 2025Board MeetingAudited Results
              Feb 12, 2025Feb 06, 2025Board MeetingQuarterly Results
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final 22%0.0-Aug 17, 1998

            • No other corporate actions details are available.

            About Godavari Drugs

            Godavari Drugs Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 61.52 Crore) operating in Pharmaceuticals sector. Godavari Drugs Ltd. key Products/Revenue Segments include Bulk Drugs, Income From Construction Work and Raw Materials for the year ending 31-Mar-2017. Show More

            • Executives

            • Auditors

            • GJ

              Ghanshyam Jaju

              Chairman
              MK

              Mukund Kakani

              Managing Director
              MJ

              Mohit Jaju

              WholeTime Director & CFO
              DU

              Dinesh Udpa

              Ind. Non-Executive Director
              Show More
            • Ayyadevara & Co.
              V Sridhar & Co.

            Industry

            Pharma - Indian

            Key Indices Listed on

            -

            Address

            1-8-303/34,Mayfair,Secunderabad, Telangana - 500003

            Contact

            [email protected]

            http://www.godavaridrugs.com

            More Details

            FAQs about Godavari Drugs share

            • 1. What's Godavari Drugs share price today and what are Godavari Drugs share returns ?
              Godavari Drugs share price is Rs 81.70 as on 16 Oct, 2025, 03:43 PM IST. Godavari Drugs share price trend:
              • Last 12 Months: Godavari Drugs share price moved down 39.10%
              • Last 3 Years: Godavari Drugs Share price moved up by 17.47%
            • 2. What is the market cap of Godavari Drugs?
              Within the Pharmaceuticals sector, Godavari Drugs stock has a market cap rank of 142. Godavari Drugs has a market cap of Rs 61.52 Cr.
            • 3. What has been highest price of Godavari Drugs share in last 52 weeks?
              In last 52 weeks Godavari Drugs share had a high price of Rs 142.50 and low price of Rs 78.91
            • 4. What are the returns for Godavari Drugs share?
              Return Performance of Godavari Drugs Shares:
              • 1 Week: Godavari Drugs share price moved up by 0.12%
              • 6 Month: Godavari Drugs share price moved down by 15.68%
            • 5. What is the PE & PB ratio of Godavari Drugs?
              The PE ratio of Godavari Drugs stands at 16.12, while the PB ratio is 1.41.

            Trending in Markets

            Top Gainers As on 03:59 PM | 16 Oct 2025

            BLS Int. Services324.50
            45.95 (16.50%)
            Craftsman Automation6,800.50
            376.50 (5.87%)
            Oberoi Realty1,687.10
            85.70 (5.36%)
            Apar Industries8,784.50
            429.00 (5.14%)
            Ola Electric Mobilit55.38
            2.64 (4.99%)

            Top Losers As on 03:59 PM | 16 Oct 2025

            KEI Industries4,172.60
            -248.00 (-5.62%)
            Anant Raj633.35
            -29.20 (-4.41%)
            Netweb Technologies3,760.20
            -172.21 (-4.38%)
            Tata Investment906.00
            -35.00 (-3.72%)
            Max Financial1,552.40
            -56.70 (-3.53%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Godavari Drugs Share Price
            The Economic Times
            BrowseCompanies: